AAAAAA
Results:
1-18
|
Results: 18
Authors:
Masquelier, B
Chaix, ML
Burgard, M
Lechenadec, J
Doussin, A
Simon, F
Cottalorda, J
Izopet, J
Tamalet, C
Douard, D
Fleury, H
Mayaux, MJ
Blanche, S
Rouzioux, C
Citation: B. Masquelier et al., Zidovudine genotypic resistance in HIV-1-infected newborns in the French Perinatal Cohort, J ACQ IMM D, 27(2), 2001, pp. 99-104
Authors:
Moynet, D
Pouliquen, JF
Londos-Gagliardi, D
Buigues, RP
Moreau, JF
Bedjabaga, I
Georges, MC
Talarmin, A
Joubert, M
Fleury, H
Vincendeau, P
Guillemain, B
Citation: D. Moynet et al., High variability of HTLV-I in a remote population of Gabon as compared to that of a similar population of French Guiana, VIRUS GENES, 23(3), 2001, pp. 257-261
Authors:
Pellegrin, I
Garrigue, I
Caumont, A
Pellegrin, JL
Merel, P
Schrive, MH
Bonot, P
Fleury, H
Citation: I. Pellegrin et al., Persistence of zidovudine-resistance mutations in HIV-1 isolates from patients removed from zidovudine therapy for at least 3 years and switched to astavudine-containing regimen, AIDS, 15(8), 2001, pp. 1071-1073
Authors:
Neau, D
Trimoulet, P
Winnock, M
Le Bail, B
Schvoerer, E
Legrand, E
Ragnaud, JM
Dupon, M
Fleury, H
Lafon, ME
Citation: D. Neau et al., Impact of protease inhibitors on intrahepatic hepatitis C virus viral load, AIDS, 15(13), 2001, pp. 1736-1738
Authors:
Merel, P
Pellegrin, I
Garrigue, I
Caumont, A
Schrive, MH
Birac, V
Bonot, P
Fleury, H
Citation: P. Merel et al., Comparison of capillary electrophoresis sequencing with the new CEQ 2000 DNA Analysis System to conventional gel based systems for HIV drug resistance analysis, J VIROL MET, 98(1), 2001, pp. 9-16
Authors:
Masquelier, B
Race, E
Tamalet, C
Descamps, D
Izopet, J
Buffet-Janvresse, C
Ruffault, A
Mohammed, AS
Cottalorda, J
Schmuck, A
Calvez, V
Dam, E
Fleury, H
Brun-Vezinet, F
Citation: B. Masquelier et al., Genotypic and penotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase(RT): Multicenter study of patients treated with RT inhibitors, ANTIM AG CH, 45(6), 2001, pp. 1836-1842
Authors:
Pellegrin, I
Segondy, M
Garrigue, I
Izopet, J
Montes, B
Pellegrin, JL
Reynes, J
Massip, P
Puel, J
Fleury, H
Citation: I. Pellegrin et al., Phenotypic resistance pattern of HIV-1 isolates with zidovudine and/or multidrug resistance mutations after didanosine-stavudine combination therapy, J ACQ IMM D, 25(5), 2000, pp. 465-466
Authors:
Aktouf, C
Fleury, H
Robach, C
Citation: C. Aktouf et al., Inserting scan at the behavioral level, IEEE DES T, 17(3), 2000, pp. 34-42
Authors:
Couturier, E
Damond, F
Roques, P
Fleury, H
Barin, F
Brunet, JB
Brun-Vezinet, F
Simon, F
Citation: E. Couturier et al., HIV-1 diversity in France, 1996-1998, AIDS, 14(3), 2000, pp. 289-296
Authors:
Garrigue, I
Pellegrin, I
Hoen, B
Dumon, B
Harzic, M
Schrive, MH
Sereni, D
Fleury, H
Citation: I. Garrigue et al., Cell-associated HIV-1-DNA quantitation after highly active antiretroviral therapy-treated primary infection in patients with persistently undetectable plasma HIV-1 RNA, AIDS, 14(18), 2000, pp. 2851-2855
Authors:
Trimoulet, P
Bernard, PH
De Ledinghen, V
Oui, B
Chene, G
Girardin, MFS
Dantin, S
Couzigou, P
Fleury, H
Citation: P. Trimoulet et al., Quantitation of hepatitis C virus RNA in plasma and peripheral blood mononuclear cells of patients with chronic hepatitis treated with interferon-alpha, DIG DIS SCI, 45(1), 2000, pp. 175-181
New molecular assays to predict occurrence of cytomegalovirus disease in renal transplant recipients
Authors:
Pellegrin, I
Garrigue, I
Ekouevi, D
Couzi, L
Merville, P
Merel, P
Chene, G
Schrive, MH
Trimoulet, P
Lafon, ME
Fleury, H
Citation: I. Pellegrin et al., New molecular assays to predict occurrence of cytomegalovirus disease in renal transplant recipients, J INFEC DIS, 182(1), 2000, pp. 36-42
Authors:
Trimoulet, P
de Ledinghen, V
Ekouevi, D
Bernard, PH
Merel, P
Chene, G
Couzigou, P
Fleury, H
Citation: P. Trimoulet et al., TT virus infection during chronic hepatitis C, AM J GASTRO, 95(7), 2000, pp. 1765-1769
Authors:
Menu, E
Reynes, JM
Muller-Trutwin, MC
Guillemot, L
Versmisse, P
Chiron, M
An, S
Trouplin, V
Charneau, P
Fleury, H
Barre-Sinoussi, F
Sainte Marie, FF
Citation: E. Menu et al., Predominance of CCR5-dependent HIV-1 subtype E isolates in Cambodia, J ACQ IMM D, 20(5), 1999, pp. 481-487
Authors:
Pellegrin, I
Izopet, J
Reynes, J
Denayrolles, M
Montes, B
Pellegrin, JL
Massip, P
Puel, J
Fleury, H
Segondy, M
Citation: I. Pellegrin et al., Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plusdidanosine combination therapy, AIDS, 13(13), 1999, pp. 1705-1709
Authors:
Lang, D
Hinderer, W
Rothe, M
Sonneborn, HH
Neipel, F
Raab, M
Rabenau, H
Masquelier, B
Fleury, H
Citation: D. Lang et al., Comparison of the immunoglobulin-G-specific seroreactivity of different recombinant antigens of the human herpesvirus 8, VIROLOGY, 260(1), 1999, pp. 47-54
Authors:
Mercie, P
Devianne, I
Viallard, JF
Faure, I
Pellegrin, I
Leng, B
Dupon, M
Barbeau, P
Fleury, H
Pellegrin, JL
Citation: P. Mercie et al., Vascular endothelial growth factor (VEGF(165)) plasma level increase with immunodepression in AIDS patients with Kaposi's sarcoma, MICROVASC R, 57(2), 1999, pp. 208-210
Authors:
Hoen, B
Dumon, B
Harzic, M
Venet, A
Dubeaux, B
Lascoux, C
Bourezane, Y
Ragnaud, JM
Bicart-See, A
Raffi, F
Beauvais, L
Fleury, H
Sereni, D
Citation: B. Hoen et al., Highly active antiretroviral treatment initiated early in the course of symptomatic primary HIV-1 infection: Results of the ANRS 053 trial, J INFEC DIS, 180(4), 1999, pp. 1342-1346
Risultati:
1-18
|